查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
医药品ADMET实验到2028年前的市场预测-COVID-19影响与实验类型，技术，各应用领域的全球分析
市场调查报告书
商品编码
1118343

医药品ADMET实验到2028年前的市场预测-COVID-19影响与实验类型，技术，各应用领域的全球分析

Pharma ADMET Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Testing Type, Technology, and Application
出版日期: | 出版商: The Insight Partners | 英文 186 Pages | 订单完成后即时交付

价格

医药品ADMET测试市场在2021年估算为67亿8,306万美元，到2028年达到135亿7,862万美元增长，市场在2022年～2028年间，预测将以年复合成长率10.5％。

本报告提供全球医药品ADMET实验市场相关调查，提供市场概要，以及各类型，技术，各应用领域，各地区的趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 简介

  • 调查目标范围
  • Insight Partners的调查报告书指导
  • 市场区隔
    • 医药品ADMET实验的全球市场- 各实验类型
    • 医药品ADMET实验的全球市场- 各技术
    • 医药品ADMET实验的全球市场:各用途
    • 医药品ADMET实验的全球市场- 各地区

第2章 医药品ADMET实验的市场-主要的要点

第3章 调查手法

  • 目标范围
  • 2次调查
  • 1次调查

第4章 医药品ADMET实验的全球市场形势- 市场展望

  • PEST分析
    • 北美的PEST分析
    • 欧洲-PEST分析
    • 亚太地区-PEST分析
    • 中东·非洲的PEST分析
    • 中南美-PEST分析
  • 专家的见解

第5章 医药品ADMET测试市场- 主要市场动态

  • 推动市场要素
  • 阻碍市场要素
  • 市场机会
  • 今后趋势
  • 促进因素和阻碍因素的影响分析

第6章 医药品ADMET测试市场-世界分析

  • 医药品ADMET实验的全球市场收益和预测及分析
  • 医药品ADME实验的全球市场，各地区预测及分析
  • 主要企业的市场定位
  • 医药品ADME实验的全球市场-各地区市场潜在力分析
  • 比较企业分析
  • 成长策略分析
  • 主要企业的业绩
    • WuXi AppTec
    • Charles River Laboratories Inc.

第7章 医药品ADMET测试市场的分析与2028年前的预测- 各实验类型

  • 医药品ADMET实验的全球市场，各实验类型2022年·2028年(%)
  • In Vivo ADMET实验
  • In Vitro ADMET实验
  • In Silico ADMET实验

第8章 医药品ADMET实验的市场分析与2028年前的预测-各技术

  • 医药品ADMET实验的全球市场，各技术2022年·2028年(%)
  • 细胞培养
  • 高通量
  • 分子影像
  • 体学技术

第9章 医药品ADMET实验的全球市场分析-各用途

  • 医药品ADMET实验的全球市场:各用途2022年·2028年(%)
  • 全身毒性
  • 肾毒性
  • 肝毒性
  • 神经毒性
  • 其他

第10章 医药品ADMET实验市场收益和2028年前的预测-各地区分析

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲地区
    • UAE
    • 沙乌地阿拉伯
    • 南非
    • 其他中东·非洲地区
  • 中南美地区
    • 中南美地区
      • 巴西
      • 阿根廷
      • 其他的中南美地区

第11章 COVID-19疫情对医药品ADMET测试市场带来的影响

  • 北美
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 中南美

第12章 医药品ADMET测试市场-产业形势

  • 参与市场企业所进行的成长策略(%)
  • 有机的发展
  • 界内有机开发

第13章 企业简介

  • CMIC HOLDINGS Co., LTD
  • Charles River Laboratories
  • WuXi AppTec
  • Promega Corporation
  • Sigma-Aldrich(MERCK KGaA)
  • Agilent Technologies, Inc.
  • Biovia(Dassault Systemes)
  • Cyprotex Limited
  • Bio-Rad Laboratories, Inc.
  • IQVIA Inc.

第14章 附录

  • The Insight Partners
  • 用语说明
Product Code: TIPRE00029509

The pharma ADMET testing market is expected to grow from US$ 6,783.06 million in 2021 to US$ 13,578.62 million by 2028; it is estimated to grow at a CAGR of 10.5% from 2022 to 2028.

The report highlights trends prevailing in the market and factors driving the market growth. The market growth is attributed to the high rate of late-stage drug failure and the increasing number of products approvals and launches. Additionally, the rise of new and emerging technologies is likely to emerge as a significant trend in the market during the forecast period. However, the high cost of ADME testing studies limits the market growth.

ADMET (absorption, distribution, metabolism, excretion, and toxicology) testing plays a critical role in drug discovery and development to understand the pharmacokinetic and pharmacodynamic properties of a drug. The testing prevents the chances of drug failure during the drug discovery phase. Thus, ADMET testing facilitates pharmaceutical companies to minimize drug discovery time, testing complications, and drug development cost.

The pre-approval expenditures for a medicine can be as high as US$ 2.56 billion, which further increases to US$ 2.87 billion in the post-approved stage. According to the study titled "Why 90% of Clinical Drug Development Fails and How to Improve It?", 2022, 90% of clinical drug development fails despite the successful implementation of many strategies. After entering clinical investigations, 9 out of 10 drug candidates fail during phase I, II, and III clinical trials, and the drug approval process. Drug candidates rejected in preclinical stages are not included in the 90% failure rate of the drugs in clinical stages, as they don't enter the phase I clinical trials. If preclinical drug candidates are included, the failure rate of drug discovery and development rises even higher than 90%. According to analyses of clinical trial data from 2010 to 2017, lacking clinical effectiveness (40-50%), uncontrollable toxicity (30%), poor drug-like qualities (10-15%), no commercial needs, and ineffective strategic planning (10%) are the four major causes of trial failure.

New drug development is both resource and time-intensive, where later clinical stages result in significant costs. The discovery and development of each new medicine that is approved for clinical use is a lengthy, expensive, and challenging process that takes over 10-15 years and costs on average over US$ 1-2 billion. To lower the attrition rate in drug research & development, it is crucial to filter and optimize the absorption, distribution, metabolism, elimination, and toxicity (ADMET) characteristics of pharmaceuticals at an early stage. It has been widely accepted that drug ADMET properties should be considered as early as possible to reduce failure rates in the clinical phase of drug discovery. In vitro and in vivo drug evaluation techniques have reached maturity in preclinical applications, and in silico technologies are gaining vast acceptance to evaluate the relevant properties of drugs in the preclinical stage. The development of software programs and in silico models is further promoting the implementation of ADMET studies. Thus, the increasing need for ADME testing in drug development boosts the pharma ADMET testing market.

Based on testing type, the pharma ADMET testing market is segmented into in vivo ADMET testing, in vitro ADMET testing, and in silico ADMET testing. In 2021, the in vivo ADMET testing segment holds the largest market share. However, the in vitro ADMET testing segment is expected to register the highest CAGR from 2022 to 2028. Based on technology, the pharma ADMET testing market is segmented into cell culture, high throughput, molecular imaging, and OMICS technology. The cell culture segment held the largest market share in 2021. However, the high throughput segment is anticipated to register the highest CAGR during the forecast period. Based on application, the pharma ADMET testing market is segmented into systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others. The systemic toxicity segment held the largest market share in 2021. However, the hepatotoxicity segment is anticipated to register the highest CAGR during 2022-2028.

Impact of COVID-19 Pandemic on Pharma ADMET Testing Market

The COVID-19 pandemic positively impacted the pharma ADMET testing market due to the increased number of researchers across APAC. During the pandemic, the demand for in vitro toxicology studies increased to study several drugs and vaccines. Additionally, the increased number of researches led to high utilization of technology instead of human resource to prevent the spread of novel coronavirus. Thus, the technology segment grew at an exponential level. Moreover, governments of APAC countries organized programs and open challenge events for researchers to come up with innovative drugs for COVID-19. Such events increased the overall research numbers due to the rise in government funding. Thus, the above-mentioned facts indicate the positive impact of COVID-19 pandemic on the pharma ADMET testing market.

Various organic and inorganic strategies are adopted by companies in the pharma ADMET testing market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players in strengthening their customer base and expanding their product portfolios. A few of the significant developments by key players in the pharma ADMET testing market are listed below.

In April 2022, Charles River Laboratories announced a collaboration with NCL to drive drug discovery projects toward finding innovative therapeutics. NLC utilizes its extensive biotech and pharmaceutical ecosystem and knowledge to carefully select high-potential, preclinical biotech research. Charles River's comprehensive preclinical development services and strategy resources provide safe, high-quality drug discovery and development, which is supporting the projects of NLC's portfolio companies together to bring life-saving drugs to patients.

In March 2022, Promega Corporation (Promega) announced a collaboration with FUJIFILM Cellular Dynamics, Inc., for advancing novel assay development for drug discovery. Under a multi-year licensing agreement, FUJIFILM Cellular Dynamics will offer a wide range of custom differentiated induced pluripotent stem cell (iPSCs) integrated with Promega biosensor and intracellular bioluminescent reporter capabilities for researchers and scientists to use as a part of novel assay development in the drug discovery process.

The Canada Foundation for Innovation (CFI), Australian Research Council (ARC), National Institute of Health (NIH), World Health Organization (WHO), the Centers for Disease Control (CDC), and the Association of the British Pharmaceutical Industry (ABPI) are a few of the major primary and secondary sources referred to while preparing the report on the pharma ADMET testing market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the pharma ADMET testing market.
  • Highlights key business priorities and focus in order to assist companies to realign their business strategies.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Pharma ADMET Testing Market - By Testing Type
    • 1.3.2 Global Pharma ADMET Testing Market - By Technology
    • 1.3.3 Global Pharma ADMET Testing Market - By Application
    • 1.3.4 Global Pharma ADMET Testing Market - By Geography

2. Pharma ADMET Testing Market- Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Pharma ADMET Testing Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East & Africa - PEST Analysis
    • 4.2.5 South & Central America - PEST Analysis
  • 4.3 Expert Opinion

5. Pharma ADMET Testing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 High Rate of Late-Stage Drug Failure
    • 5.1.2 Increasing Number of Product Approvals and Launches
  • 5.2 Market Restraints
    • 5.2.1 High Cost of ADME Testing Studies
  • 5.3 Market Opportunities
    • 5.3.1 Automation and Advancements in ADME Testing
  • 5.4 Future Trends
    • 5.4.1 The Advent of High-Throughput Screening
  • 5.5 Impact Analysis

6. Pharma ADMET Testing Market- Global Analysis

  • 6.1 Global Pharma ADMET Testing Market Revenue Forecast and Analysis
  • 6.2 Global Pharma ADME Testing Market, By Geography - Forecast, and Analysis
  • 6.3 Market Positioning of Key Players
  • 6.4 Global Pharma ADME Testing Market - Market Potential Analysis, By Region
  • 6.5 Comparative Company Analysis
  • 6.6 Growth Strategy Analysis
  • 6.7 Performance of Key Players
    • 6.7.1 WuXi AppTec
    • 6.7.2 Charles River Laboratories Inc.

7. Pharma ADMET Testing Market Analysis And Forecasts To 2028 - By Testing Type

  • 7.1 Overview
  • 7.2 Global Pharma ADMET Testing Market, By Testing Type 2022 & 2028 (%)
  • 7.3 In Vivo ADMET Testing
    • 7.3.1 Overview
    • 7.3.2 In Vivo ADMET Testing - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 In Vitro ADMET Testing
    • 7.4.1 Overview
    • 7.4.2 In Vitro ADMET Testing Revenue and Forecast to 2028 (US$ Million)
  • 7.5 In Silico ADMET Testing
    • 7.5.1 Overview
    • 7.5.2 In Silico ADMET Testing Revenue and Forecast to 2028 (US$ Million)

8. Pharma ADMET Testing Market Analysis And Forecasts To 2028 - By Technology

  • 8.1 Overview
  • 8.2 Global Pharma ADMET Testing Market, By Technology 2022 & 2028 (%)
  • 8.3 Cell Culture
    • 8.3.1 Overview
    • 8.3.2 Cell Culture - Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 High Throughput
    • 8.4.1 Overview
    • 8.4.2 High Throughput - Market Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Molecular Imaging
    • 8.5.1 Overview
    • 8.5.2 Molecular Imaging - Market Revenue and Forecast to 2028 (US$ Million)
  • 8.6 OMICS Technology
    • 8.6.1 Overview
    • 8.6.2 OMICS Technology - Market Revenue and Forecast to 2028 (US$ Million)

9. Global Pharma ADMET Testing Market Analysis- By Application

  • 9.1 Overview
  • 9.2 Global Pharma ADMET Testing Market, By Application 2022 & 2028 (%)
  • 9.3 Systemic Toxicity
    • 9.3.1 Overview
    • 9.3.2 Systemic Toxicity - Market Revenue And Forecasts To 2028 (US$ Million)
  • 9.4 Renal Toxicity
    • 9.4.1 Overview
    • 9.4.2 Renal Toxicity - Market Revenue And Forecasts To 2028 (US$ Million)
  • 9.5 Hepatotoxicity
    • 9.5.1 Overview
    • 9.5.2 Hepatotoxicity - Market Revenue And Forecasts To 2028 (US$ Million)
  • 9.6 Neurotoxicity
    • 9.6.1 Overview
    • 9.6.2 Neurotoxicity - Market Revenue And Forecasts To 2028 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others - Revenue And Forecasts To 2028 (US$ Million)

10. Pharma ADMET Testing Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 10.1 North America: Pharma ADMET Testing Market
    • 10.1.1 Overview
    • 10.1.2 North America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)
    • 10.1.4 North America: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)
    • 10.1.5 North America: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)
    • 10.1.6 North America: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
      • 10.1.6.1 US: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)
        • 10.1.6.1.4 US: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)
        • 10.1.6.1.5 US: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)
      • 10.1.6.2 Canada: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)
      • 10.1.6.3 Mexico: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)
  • 10.2 Europe: Pharma ADMET Testing Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.4 Europe: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    • 10.2.5 Europe: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.6 Europe: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
      • 10.2.6.1 Germany: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Germany: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.2 Germany: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 Germany: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.4 Germany: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.2 UK: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 UK: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.2 UK: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 UK: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.4 UK: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.3 France: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 France: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.2 France: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 France: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.4 France: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.4 Italy: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Italy: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.2 Italy: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.4 Italy: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.5 Spain: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Spain: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.2 Spain: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.4 Spain: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Rest of Europe: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.2 Rest of Europe: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • 10.3 Asia Pacific Pharma ADMET Testing Market Revenue and Forecasts To 2028
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
    • 10.3.6 Asia Pacific: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)
      • 10.3.6.1 China: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.1.3 China: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
        • 10.3.6.1.4 China: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
        • 10.3.6.1.5 China: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
      • 10.3.6.2 Japan: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.2.3 Japan: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
        • 10.3.6.2.4 Japan: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
        • 10.3.6.2.5 Japan: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
      • 10.3.6.3 India: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.3.3 India: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
        • 10.3.6.3.4 India: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
        • 10.3.6.3.5 India: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
      • 10.3.6.4 South Korea: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 South Korea: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
        • 10.3.6.4.5 South Korea: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
      • 10.3.6.5 Australia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 Australia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.5.3 Australia: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
        • 10.3.6.5.4 Australia: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
        • 10.3.6.5.5 Australia: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
  • 10.4 Middle East & Africa: Pharma ADMET Testing Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
    • 10.4.3 Middle East & Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
    • 10.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    • 10.4.5 Middle East & Africa: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.6 Middle East & Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)
      • 10.4.6.1 UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.1.3 UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
        • 10.4.6.1.4 UAE: Pharma ADMET Testing Market Revenue and Forecasts To 2028, By Technology (US$ Million)
        • 10.4.6.1.5 UAE: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.2 Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.2.3 Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
        • 10.4.6.2.4 Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts To 2028, By Technology (US$ Million)
        • 10.4.6.2.5 Saudi Arabia: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.3 South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 South Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.3.3 South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
        • 10.4.6.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Technology (US$ Million)
        • 10.4.6.3.5 South Africa: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.4 Rest of Middle East and Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.4.1 Overview
        • 10.4.6.4.2 Rest of Middle East and Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.4.3 Rest of Middle East & Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Technology (US$ Million)
        • 10.4.6.4.5 Rest of Middle East and Africa: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 South & Central America: Pharma ADMET Testing Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
    • 10.5.3 South and Central America: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (USD Million)
    • 10.5.4 South and Central America: Pharma ADMET Testing Market, by Technology, 2019-2028 (USD Million)
    • 10.5.5 South and Central America: Pharma ADMET Testing Market, by Application, 2019-2028 (USD Million)
    • 10.5.6 South and Central America: Pharma ADMET Testing Market, by country, 2021 & 2028 (%)
      • 10.5.6.1 Brazil: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
        • 10.5.6.1.1 Brazil: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
        • 10.5.6.1.2 Brazil: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (USD Million)
        • 10.5.6.1.3 Brazil: Pharma ADMET Testing Market, by Technology, 2019-2028 (USD Million)
        • 10.5.6.1.4 Brazil: Pharma ADMET Testing Market, by Application, 2019-2028 (USD Million)
      • 10.5.6.2 Argentina: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
        • 10.5.6.2.1 Argentina: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
        • 10.5.6.2.2 Argentina: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (USD Million)
        • 10.5.6.2.3 Argentina: Pharma ADMET Testing Market, by Technology, 2019-2028 (USD Million)
        • 10.5.6.2.4 Argentina: Pharma ADMET Testing Market, by Application, 2019-2028 (USD Million)
      • 10.5.6.3 Rest of South and Central America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
        • 10.5.6.3.1 Rest of South and Central America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
        • 10.5.6.3.2 Rest of South and Central America: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (USD Million)
        • 10.5.6.3.3 Rest of South and Central America: Pharma ADMET Testing Market, by Technology, 2019-2028 (USD Million)
        • 10.5.6.3.4 Rest of South and Central America: Pharma ADMET Testing Market, by Application, 2019-2028 (USD Million)

11. Impact of COVID-19 Pandemic on Pharma ADMET Testing Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Pharma ADMET Testing Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 CMIC HOLDINGS Co., LTD
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Charles River Laboratories
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 WuXi AppTec
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Promega Corporation
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Sigma-Aldrich (MERCK KGaA)
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Agilent Technologies, Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Biovia (Dassault Systemes)
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Cyprotex Limited
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Bio-Rad Laboratories, Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 IQVIA Inc.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (USD Million)
  • Table 3. North America Pharma ADMET Testing Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Mexico: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Europe: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Germany: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Germany: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Germany: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. UK: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. UK: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UK: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. France: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. France: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 24. France: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Italy: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Spain: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Rest of Europe: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Asia Pacific: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Asia Pacific: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Asia Pacific: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. China: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. China: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. China: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Japan: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Japan: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Japan: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. India: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. India: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. India: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. South Korea: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. South Korea: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. South Korea: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Australia: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Australia: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Australia: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Asia Pacific: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Asia Pacific: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Asia Pacific: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Middle East & Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
  • Table 56. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 57. Middle East & Africa: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
  • Table 59. UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 60. UAE: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
  • Table 62. Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 63. Saudi Arabia: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. South Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
  • Table 65. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 66. South Africa: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Rest of Middle East & Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
  • Table 68. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 69. Rest of Middle East and Africa: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. South and Central America: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (USD Million)
  • Table 71. South and Central America: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 72. South and Central America: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 73. Brazil: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (USD Million)
  • Table 74. Brazil: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 75. Brazil: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 76. Argentina: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (USD Million)
  • Table 77. Argentina: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 78. Argentina: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 79. Rest of South and Central America: Pharma ADMET Testing Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 80. Rest of South and Central America: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 81. Rest of South and Central America: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 82. Organic Developments Done by Companies
  • Table 83. Inorganic Developments Done by Companies
  • Table 84. Glossary of Terms

List Of Figures

  • Figure 1. Pharma ADMET Testing Market Segmentation
  • Figure 2. Pharma ADMET Testing Market, By Region
  • Figure 3. Global Pharma ADMET Testing Market Overview
  • Figure 4. In vivo ADMET Testing Segment Held Largest Share of Testing Type Segment in Pharma ADMET Testing Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Pharma ADMET Testing Market, by Geography (US$ Million)
  • Figure 7. Global Pharma ADMET Testing Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Pharma ADMET Testing Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. South & Central America: PEST Analysis
  • Figure 14. Pharma ADMET Testing Market Impact Analysis of Driver and Restraints
  • Figure 15. Global Pharma ADME Testing Market- Revenue Forecast and Analysis - 2022 - 2028
  • Figure 16. Global Pharma ADME Testing Market - By Geography Forecast and Analysis - 2022 - 2028
  • Figure 17. Market Positioning of Key Players in Pharma ADME Testing Market
  • Figure 18. Global Pharma ADME Testing Market - Market Potential Analysis, By Region
  • Figure 19. Global Pharma ADME Testing Market - Comparative Company Analysis
  • Figure 20. Global Pharma ADME Testing Market - Growth Strategy Analysis
  • Figure 21. Global Pharma ADMET Testing Market, by Testing Type 2022 & 2028 (%)
  • Figure 22. In Vivo ADMET Testing - Revenue and Forecasts to 2028 (US$ Million)
  • Figure 23. In Vitro ADMET Testing Revenue and Forecasts to 2028 (US$ Million)
  • Figure 24. In Silico ADMET Testing Revenue and Forecasts to 2028 (US$ Million)
  • Figure 25. Global Pharma ADMET Testing Market, by Technology 2022 & 2028 (%)
  • Figure 26. Cell Culture - Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 27. High Throughput - Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 28. Molecular Imaging - Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 29. OMICS Technology - Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 30. Global Pharma ADMET Testing Market, by Application 2022 & 2028 (%)
  • Figure 31. Systemic Toxicity - Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 32. Renal Toxicity - Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 33. Hepatotoxicity - Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 34. Neurotoxicity - Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 35. Others - Revenue And Forecasts To 2028 (US$ Million)
  • Figure 36. North America: Pharma ADMET Testing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 37. North America Pharma ADMET Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. North America: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
  • Figure 39. US: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Canada: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Mexico: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Europe: Pharma ADMET Testing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 43. Europe: Pharma ADMET Testing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Europe: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
  • Figure 45. Germany: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. UK: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. France: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Italy: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Spain: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Rest of Europe: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Asia Pacific Pharma ADMET Testing Market Overview, by Country (2022)
  • Figure 52. Asia Pacific: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 53. Asia Pacific: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 54. China: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 55. Japan: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 56. India: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 57. South Korea: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 58. Australia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 59. Rest of Asia Pacific: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. Middle East & Africa Pharma ADMET Testing Market Revenue Overview, by Country, 2022 (US$ Million)
  • Figure 61. Middle East & Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 62. Middle East & Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 63. UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 64. Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 65. South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 66. Rest of Middle East and Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 67. South and Central America: Pharma ADMET Testing Market, by Key Country - Revenue (2022) (US$' Million)
  • Figure 68. South and Central America Pharma ADMET Testing Market Revenue and Forecast to 2028 (USD Million)
  • Figure 69. South and Central America: Pharma ADMET Testing Market, by country, 2021 & 2028 (%)
  • Figure 70. Brazil: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 71. Argentina: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 72. Rest of South and Central America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 73. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 74. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 75. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 76. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 77. Impact of COVID-19 Pandemic in South and Central American Countries
  • Figure 78. Growth Strategies Done by the Companies in the Market, (%)